[go: up one dir, main page]

DE69624343D1 - Pharmazeutische zusammensetzungen, welche ein benzydamin oder deren salz und einen antimikrobiellen wirkstoff enthalten - Google Patents

Pharmazeutische zusammensetzungen, welche ein benzydamin oder deren salz und einen antimikrobiellen wirkstoff enthalten

Info

Publication number
DE69624343D1
DE69624343D1 DE69624343T DE69624343T DE69624343D1 DE 69624343 D1 DE69624343 D1 DE 69624343D1 DE 69624343 T DE69624343 T DE 69624343T DE 69624343 T DE69624343 T DE 69624343T DE 69624343 D1 DE69624343 D1 DE 69624343D1
Authority
DE
Germany
Prior art keywords
benzydamine
salt
pharmaceutical compositions
active substance
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Revoked
Application number
DE69624343T
Other languages
English (en)
Other versions
DE69624343T2 (de
Inventor
Diego Oldani
C O Francese
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline SpA
Original Assignee
GlaxoSmithKline SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11370720&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69624343(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by GlaxoSmithKline SpA filed Critical GlaxoSmithKline SpA
Application granted granted Critical
Publication of DE69624343D1 publication Critical patent/DE69624343D1/de
Publication of DE69624343T2 publication Critical patent/DE69624343T2/de
Anticipated expiration legal-status Critical
Revoked legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4425—Pyridinium derivatives, e.g. pralidoxime, pyridostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Birds (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69624343T 1995-02-28 1996-02-19 Pharmazeutische zusammensetzungen, welche ein benzydamin oder deren salz und einen antimikrobiellen wirkstoff enthalten Revoked DE69624343T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI950379A IT1274655B (it) 1995-02-28 1995-02-28 Composizioni farmaceutiche contenenti un agente antiinfiammatorio e un agente antimicrobico
PCT/EP1996/000713 WO1996026724A1 (en) 1995-02-28 1996-02-19 Pharmaceutical compositions containing a benzydamine or its salt and an antimicrobial agent

Publications (2)

Publication Number Publication Date
DE69624343D1 true DE69624343D1 (de) 2002-11-21
DE69624343T2 DE69624343T2 (de) 2003-07-31

Family

ID=11370720

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69624343T Revoked DE69624343T2 (de) 1995-02-28 1996-02-19 Pharmazeutische zusammensetzungen, welche ein benzydamin oder deren salz und einen antimikrobiellen wirkstoff enthalten

Country Status (8)

Country Link
EP (1) EP0812193B1 (de)
JP (1) JPH11501019A (de)
AU (1) AU4940396A (de)
DE (1) DE69624343T2 (de)
HK (1) HK1006224A1 (de)
IT (1) IT1274655B (de)
WO (1) WO1996026724A1 (de)
ZA (1) ZA961514B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003089007A1 (en) * 2002-04-22 2003-10-30 Adcock Ingram Intellectual Property (Proprietary) Limited Pharmaceutical compositions comprising a decongenstant and further active ingredients for treating cough and flu
US6913759B2 (en) * 2003-03-11 2005-07-05 Curatek Pharmaceuticals Holding, Inc. Gel composition and method for treatment of vaginal infections
DE102004037598A1 (de) * 2004-08-03 2006-02-23 Prontomed Gmbh Mundspüllösung
ES2605794T3 (es) 2006-07-20 2017-03-16 Izun Pharmaceuticals Corporation Película, parche o formulación sólida adhesiva que comprende Sambucus nigra, Centella asiatica y sal de 1-alquilpiridinio para el tratamiento de tejidos mucosos
KR101723996B1 (ko) * 2009-07-08 2017-04-06 아지엔드 키미쉐 리유나이트 안젤리니 프란체스코 에이.씨.알.에이.에프. 에스.피.에이 ｐ40 의존형 질환의 치료에서 벤지다민의 용도
US9962372B2 (en) * 2015-01-13 2018-05-08 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. Pharmaceutical composition for the treatment of mycosis
WO2016126217A1 (en) * 2015-02-03 2016-08-11 Pharmacti̇ve Ilaç Sanayi̇ Ve Ti̇caret A. Ş. Stable pharmaceutical combination containing benzydamine
JP6758955B2 (ja) * 2016-06-30 2020-09-23 サンスター株式会社 口腔用ペースト状組成物
JP6879681B2 (ja) * 2016-06-30 2021-06-02 サンスター株式会社 ラミネートチューブ容器用の口腔用ペースト状組成物
KR102461699B1 (ko) * 2021-05-21 2022-11-03 현대약품 주식회사 벤지다민염산염을 포함하는 안정성이 개선된 가글액

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2607945B2 (ja) * 1989-01-12 1997-05-07 サンスター株式会社 歯周組織修復促進組成物
GB9224598D0 (en) * 1992-11-24 1993-01-13 Smithkline Beecham Plc Novel compositions

Also Published As

Publication number Publication date
DE69624343T2 (de) 2003-07-31
HK1006224A1 (en) 1999-02-19
ZA961514B (en) 1996-11-06
JPH11501019A (ja) 1999-01-26
ITMI950379A1 (it) 1996-08-28
ITMI950379A0 (it) 1995-02-28
EP0812193B1 (de) 2002-10-16
EP0812193A1 (de) 1997-12-17
IT1274655B (it) 1997-07-18
AU4940396A (en) 1996-09-18
WO1996026724A1 (en) 1996-09-06

Similar Documents

Publication Publication Date Title
FI962589L (fi) 2,4-disulfofenyylibutyylinitroni, sen suolat ja niiden käyttö farmaseuttisina aineina
CA2170647A1 (en) Multiple unit tableted dosage form i
DE69713287D1 (de) Verbindungen von wirkstoffen, welche klopidogrel und antithrombotische mittel enthalten
DE69526958D1 (de) Antibakterielle oder bakterizide mittel, die 2-aminothiazolderivate und deren salze enthalten
FI952920L (fi) 7-halogeeni- ja 7beta,8beta-metano-taksolit, niiden antineoplastinen käyttö ja niitä sisältävät farmaseuttiset koostumukset
EE9800028A (et) Iprotroopiumsoolad, neid sisaldavad ravimkompositsioonid ja nende kasutamine
HUP9602601A3 (en) Piperidine and piperazine derivatives, medicines containing them as active ingredient and their use
DE69912781T2 (de) Zwei oder mehrere wirkstoffe enthaltende pharmazeutische aerosolformulierungen
TR199500826A2 (tr) Multipl ünite tablet doz formu 2.
DE69606028D1 (de) Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammensetzung
DE69202060D1 (de) OPTISCH AKTIVES 5H-PYRROLO[3,4-b]PYRAZINDERIVAT, SEINE HERSTELLUNG UND PHARMAZEUTISCHE ZUBEREITUNGEN DIE ES ENTHALTEN.
DE3863366D1 (de) Antibiotikum vermisporin, verfahren zu dessen herstellung und dasselbe als aktiver antibakterieller wirkstoff enthaltende pharmazeutische zusammensetzung.
DE69630145D1 (de) Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
AU3091489A (en) Piperazine derivative or its salt, process for producing the same and pharmaceutical composition comprising the same as active ingredient
DE69624343D1 (de) Pharmazeutische zusammensetzungen, welche ein benzydamin oder deren salz und einen antimikrobiellen wirkstoff enthalten
DE69803565D1 (de) Antivirale pharmazeutische zusammensetzungen welche glycyrrhizinsäure und mindestens ein protein mit antiviraler wirksamkeit enthalten
ATE170854T1 (de) Heterocyclische, aromatische verbindungen, pharmazeutische und kosmetische zusammensetzungen,die sie enthalten, und verwendungen.
DE69605525D1 (de) Bio-aromatische, eine Adamantylgruppe in para-Position enthaltende Verbindungen, diese enthaltende pharmazeutische und kosmetische Zusammensetzungen und ihre Verwendung
ATE193533T1 (de) Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
FR2663326B2 (fr) Derives de la pyridazine, procede de preparation et compositions pharmaceutiques en contenant.
FR2687401B1 (fr) Derives de la 1,4-dialkylpiperazine, procedes d'obtention et compositions pharmaceutiques les contenant.
FR2703995B1 (fr) 5-acylamino 1,2,4-thiadiazoles, leur preparation et compositions pharmaceutiques en contenant.
DE69722433D1 (de) Pharmazeutische zubereitungen, welche zidovudin und lamivudine enthalten
DE69318153D1 (de) Antihypercholesterämisch-wirksame verbindungen, pharmazeutische präparate und verwendungen davon
AU5260096A (en) Novel pyridonecarboxylic acid derivatives or salts thereof and antibacterial agent containing the same as active ingredient

Legal Events

Date Code Title Description
8363 Opposition against the patent
8331 Complete revocation